A breakthrough for diabetes management arrived on March 6th with the FDA‘s approval of Dexcom’s Stelo glucose biosensor system. This revolutionary device, the first of its kind, allows for over-the-counter, prescription-free blood sugar monitoring for individuals with non-insulin-dependent diabetes or those at risk of developing the condition.

The glucose monitor displays readings every 15 minutes

Unlike traditional methods, Stelo utilizes a wearable sensor and smartphone app to continuously monitor glucose levels, displaying readings every 15 minutes. Each sensor lasts up to 15 days before needing replacement, offering a convenient and long-lasting solution.

The FDA highlighted the significance of this approval, emphasizing its potential to increase accessibility to blood sugar monitoring and empower individuals to manage their health from the comfort of their homes.

While Stelo represents a major step forward, the ultimate goal in diabetes management remains non-invasive blood glucose monitoring. This technology, though initially planned for the Apple Watch, has yet to be realized due to current limitations. The FDA also cautions against unapproved non-invasive alternatives, stressing their unreliability.

Despite the current absence of non-invasive options, Dexcom’s Stelo marks a significant advancement in diabetes management, offering a convenient and accessible solution for many people. The future of blood sugar monitoring, however, holds the promise of even more innovative and non-invasive approaches.

RELATED:

• Samsung Galaxy Watch receives FDA approval for sleep apnea detection
• Neuralink Receives Approval from FDA for Human Testing
• Get latest Oneplus 12 Phone for $699 on Geekwills
• Get $100 OFF on Xiaomi 14 Pro at Giztop (1TB Variant)
• Lenovo Legion Y700 2023: Save $100 on this 8-inch gaming Android tablet
• How to add/remove someone in a WhatsApp group (with screenshots)

(Via)

The post FDA Approves First OTC Glucose Monitor, Dexcom’s Stelo System – and it can Pair with your Smartphone appeared first on Gizmochina.

In the realm of wearable technology, health-related features have become increasingly important. Apple has long been rumored to be working on non-invasive blood sugar monitoring for its Apple Watch, but it seems that Huawei has beaten them to the punch. The recently unveiled Huawei Watch 4 boasts a groundbreaking feature that detects the risk of high blood sugar, marking a significant advancement in wearable health technology.

Huawei tested over 800,000 blood sugar metrics over 100,000 hours

For individuals living with diabetes, managing blood sugar levels is crucial. Traditionally, diabetics have relied on painful and costly blood tests performed multiple times a day using lancets and glucometers. Huawei’s innovation offers a non-invasive alternative that monitors blood sugar levels through a comprehensive analysis of ten health indicators in just 60 seconds. While the Huawei Watch 4 does not provide on-demand blood sugar readings, it offers timely alerts to help users make informed decisions about their diet and sugar intake.

Huawei’s achievement is the result of extensive research and collaboration with reputable medical institutions. Through rigorous testing of over 800,000 blood sugar data points over 100,000 hours, Huawei has developed a reliable and accurate health monitoring system. The Huawei Watch 4 tracks heart rate, pulse wave characteristics, and other key indicators to assess the risk of hyperglycemia.

To utilize this feature, users must participate in a blood sugar health research program conducted by a third-party medical institution and be above 18 years of age. It is important to note that the Huawei Watch 4 is not classified as a medical device; rather, the information it provides serves as a reference. Additionally, individuals with type 1 diabetes are not advised to use this technology, as their pancreas does not produce insulin. However, type 2 diabetics, who experience reduced insulin production over time and insulin resistance, can benefit from the Huawei Watch 4’s blood sugar monitoring feature.

Initially, this cutting-edge feature will be limited to models sold in the Chinese market. The Huawei Watch 4 boasts a 1.5-inch AMOLED display and is powered by HarmonyOS 3.1. It offers various health-related functions, including blood oxygen readings and electrocardiogram (ECG) analysis. The device provides up to three days of battery life and is water-resistant up to 5ATM. Different models and colors are available to suit individual preferences.

RELATED:

• Huawei Nova Y91 launched with 6.95-inch display, 7,000mAh battery, 256GB storage
• Huawei HiSilicon V811 chip launched with Dangbei F6 4K projector, supports 8K30Hz decoding
• Best Budget-friendly Drawing Tablets in 2023

(Via)

The post Huawei Watch 4 Introduces Blood Sugar Monitoring before Apple appeared first on Gizmochina.

It’s been a long time since we first heard rumors about Apple planning to add Blood Glucose Monitoring support to the Apple Watch as a part of its health-related services.

Earlier this year, it was reported that the company had made major progress in the development, which led to speculations that it could get launched soon, but now a new report claims that the device isn’t coming anytime soon.

As per the latest report coming from Mark Gurman, the Apple Watch with support for the Blood Glucose Monitoring feature is still several years away. He indicates that the device will take somewhere between three to seven years to go official.

It is said that the Cupertino-based technology giant still needs to work on the algorithms and onboard sensors to be able to bring the technology to market. Further, the size of a module also needs to be reduced to fit the small and thin package of the Apple Watch.

For Apple, it has been a long journey working on introducing a Blood Glucose Monitoring technology. It reportedly first started working on it in 2010 with the acquisition of RareLight, and then it worked with Avolante Health LLC before moving to Exploratory Design Group (XDG).

The goal for Apple appears to be able to warn users of its smartwatch devices if they are prediabetic and suggest lifestyle changes before diabetes develops. It is speculated that the company is in the early stages of discussions to get regulatory approval for the technology.

RELATED:

• Apple Watch Camera Becomes Probable as Company Seeks Patent for Face ID
• Apple Autonomous Vehicle Program Grows to Over 200 Drivers with One Minor Collision
• Apple’s WWDC 2023 Keynote Rumored for June 5: What to Expect
• Apple Secures Patent for NFC-Enabled Watch Bands: A Step Forward or a Crackdown on Third-Party Accessories?
• Apple May Have Lowered A17 Bionic Performance Goals for iPhone 15 Pro Lineup

Source

The post Apple Watch with Blood Glucose Monitoring feature isn’t coming anytime soon appeared first on Gizmochina.

We have witnessed a raft of announcements of a broad array of products that will be showcased in CES 2022, which begins on Wednesday, January 5th at the Las Vegas Convention Center in the United States. Quantum Operation Inc has announced the release of its first smartwatch that offers blood glucose measurement via a non-invasive and proprietary technology.

At the last count, more than 2200 exhibitors will showcase their products during the most influential tech event this year, CES 2022. It will feature innovative products from a broad array of tech fields ranging from health, entertainment, fitness, mobility, and a whole lot more, and Quantum Operations is pitching itself into the fray with its smartwatch offering. The company says the new smartwatch will be of great assistance to diabetics who need to monitor their blood sugar levels regularly.

The watch features the possibility of monitoring the blood sugar levels pre and post-meal to check for changes in the metric. The smartwatch also features heart rate and blood oxygen monitoring to provide all-around health support. Quantum has released a video of the smartwatch which seems to yet to be out as a commercial product. It will however showcase a prototype of the smartwatch during CES 2022.

There has been a surge of innovative products that capture some of the very important health measurements and vital statistics using smart wearables. These sensors are capable of measuring heart rate, blood sugar, blood pressure, stress, and now, blood glucose levels. Quantum will hope that its new smartwatch will enjoy some great outings during CES 2022, although it is not the first brand to offer non-invasive blood glucose monitoring.

RELATED:

• HUAWEI WATCH FIT mini China launch tipped for this month
• Pangu M900 could be Huawei’s next ARM chip for computers
• Huawei may launch Mate 40E Pro with Kirin 990 5G as Kirin 9000 SoC stock runs dry
• Huawei HiSilicon Hi3731V110 is a new FHD TV chip based on RISC-V architecture

(via)

The post Quantum Operation unveils a smartwatch with non-invasive blood glucose monitoring appeared first on Gizmochina.

Last month, a report said that the next Apple Watch (Tentatively Apple Watch 7) could get the Blood Sugar Monitoring feature. Now, a series of patents unearthed by Apple Insider shows that Apple could be working on a new Terahertz Sensor for the non-invasive Glucose monitoring.

A total of four patients with one main and three other resembling ones(via AppleInsider)have been filed at USPTO(US Patent and Trademark Office). Although none have the word Glucose/Blood Sugar monitoring, they hover around the Absorption Spectroscopy on Electronic devices.

If you recall, a company named Quantum Operation showed off a “Spectrometer-based” prototype that works on the interaction of light with the wrist at CES 2021. Here, Apple’s patents delves on using Ambient Sensors for Terahertz Spectroscopy and Imaging in Dynamic Environments.

Apple begins with limitations like lack of Space for New Sensors with Aperture/opening, Degraded Water resistivity, overall cost increase, etc. of the previous ‘Gas Sensor’ design. Consequently, its new patent talks about using terahertz(THz) electromagnetic radiation(EMR) on previous spectroscopy methods.

A transmitter of the electronic device will emit EM waves in THz into a dynamic environment like a user’s skin. A receiver will then absorb the reflected wave back. Following this, a spectral response having absorption Spectra(data about the Obstacle) is compared with known Spectra(Fixed values).

Apple adds that this tech might go beyond the borders of non-invasive Glucose monitoring. It says that absorption spectroscopy will play a vital role in overall health including detecting skin cancers/disorders in the future.

Either way, the technology is new and immature so it needs a lot of studies as currently, it might have discrepancies with that of Hospital Monitoring techniques.

RELATED:

• Apple Watch’s heart rate sensor can predict COVID-19 a week before a Swab Test: Report
• Apple and Samsung leads as top Semiconductor customers in 2020
• Apple Watch saves the life of a British cyclist caught in a flooded river

The post Apple could be working on terahertz radiation sensor for non-invasive Glucose Monitoring appeared first on Gizmochina.

CES 2021 is blowing up with a lot of announcements despite being a virtual event. Among the lot, a Japanese Startup now says that its wearable can help you monitor Blood Glucose without piercing your skin.

Quantum Operation Inc., has showcased a prototype of a Wearable that typically is like a Smartwatch. It says that the wearable can measure and monitor the Glucose levels in Blood precisely in addition to heart rate and ECG. Apparently, this is possible due to the presence of a Spectrometer inside.

On wearing it on the wrist, a user will have to just press the monitoring option from the Menu. The results will take about 20 seconds. If you consider Blood Glucose monitoring so far it requires a person to pierce his/her fingers or use an implanted monitor. However, this prototype reportedly uses the principle of the Raman Spectroscopy technique.

EDITOR’S PICK: Amazfit GTS 2e and Amazfit GTR 2e announced at CES 2021; GTR 2 LTE coming later

It is an interaction of light with the chemical bonds of a material. This technique finds its significance in Noninvasive glucose monitoring according to various projects in the past. Reports say that a laser passed through a fiber optic cable can help monitor Glucose by pressing it against the wrist.

Having said that, Quantum is not the only one to try this idea. Several companies including Apple themselves have worked on it in the past. In fact, Apple’s patent(via) shows a concept similar to the spectroscopy technique. Coming back, the initial data sample provided by Quantum Operation reportedly has a lot of fluctuations compared to traditional flash glucose monitoring.

Considering this as just a prototype, we can let it slide. However, the company should work more on the accuracy if it plans to make this a working solution. Speaking of which, Quantum says that it plans to sell this wearable to healthcare professionals, insurers and build a big data platform to test the information of patients more.

UP NEXT: CES 2021: TCL showcases marvelous rollable OLED smartphone and 17-inch scrolling display

(via)

The post CES 2021: Quantum Operation shows a prototype of a Wearable with Noninvasive glucose monitoring feature appeared first on Gizmochina.